Literature DB >> 12795620

Function of the MexB efflux-transporter divided into two halves.

Shima Eda1, Hiroshi Yoneyama, Taiji Nakae.   

Abstract

The MexA-MexB-OprM efflux pump exports structurally and functionally diverse xenobiotics and confers multi-drug resistance on Pseudomonas aeruginosa cells. The MexB transporter traverses the inner membrane twelve times, bears two large periplasmic domains and has two homologous tandem repeats. To test whether two homologous halves of MexB function independently or interdependently, the protein was divided medially into two halves, each consisting of six amino- and carboxyl-proximal transmembrane segments. When two halves of MexB were coexpressed from independent open reading frames, the cells lacking chromosomal mexB exhibited restored antibiotic resistance at a level close to that in the cells producing a full-length MexB. In contrast, MexB protein containing either an amino- or carboxyl-half fragment failed to transport antibiotics. To test whether the amino- and carboxyl-proximal halves were present in a complex, we purified the histidine-tagged carboxyl-proximal half molecule using nickel-chelate chromatography from the cells that coexpressed two halves. The results showed that the nonhistidine-tagged amino-proximal half was co-purified with the carboxyl-proximal half, thereby indicating that the amino-proximal half fragment was tightly associated with the carboxyl-proximal half molecule. These findings suggest that the presence of both amino- and carboxyl-halves of MexB in a complex is essential for transport activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12795620     DOI: 10.1021/bi0300074

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance.

Authors:  Pilar Domenech; Michael B Reed; Clifton E Barry
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

2.  Characterization of immunodominant and potentially protective epitopes of Mannheimia haemolytica serotype 1 outer membrane lipoprotein PlpE.

Authors:  Sahlu Ayalew; Anthony W Confer; Emily R Blackwood
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

3.  Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.

Authors:  Leonie Greipel; Sebastian Fischer; Jens Klockgether; Marie Dorda; Samira Mielke; Lutz Wiehlmann; Nina Cramer; Burkhard Tümmler
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

4.  Differential impact of MexB mutations on substrate selectivity of the MexAB-OprM multidrug efflux pump of Pseudomonas aeruginosa.

Authors:  Jocelyn K Middlemiss; Keith Poole
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

5.  Exploring the HME and HAE1 efflux systems in the genus Burkholderia.

Authors:  Elena Perrin; Marco Fondi; Maria Cristiana Papaleo; Isabel Maida; Silvia Buroni; Maria Rosalia Pasca; Giovanna Riccardi; Renato Fani
Journal:  BMC Evol Biol       Date:  2010-06-03       Impact factor: 3.260

Review 6.  Assembly and transport mechanism of tripartite drug efflux systems.

Authors:  Rajeev Misra; Vassiliy N Bavro
Journal:  Biochim Biophys Acta       Date:  2009-03-13

7.  Energy-coupling mechanism of the multidrug resistance transporter AcrB: Evidence for membrane potential-driving hypothesis through mutagenic analysis.

Authors:  Min Liu; Xuejun C Zhang
Journal:  Protein Cell       Date:  2017-08       Impact factor: 14.870

8.  Molecular Determinants of the Promiscuity of MexB and MexY Multidrug Transporters of Pseudomonas aeruginosa.

Authors:  Venkata K Ramaswamy; Attilio V Vargiu; Giuliano Malloci; Jürg Dreier; Paolo Ruggerone
Journal:  Front Microbiol       Date:  2018-06-01       Impact factor: 5.640

9.  Coupling of remote alternating-access transport mechanisms for protons and substrates in the multidrug efflux pump AcrB.

Authors:  Thomas Eicher; Markus A Seeger; Claudio Anselmi; Wenchang Zhou; Lorenz Brandstätter; François Verrey; Kay Diederichs; José D Faraldo-Gómez; Klaas M Pos
Journal:  Elife       Date:  2014-09-19       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.